New Tests Launched in December
In December 2018, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in December 2018 by Mayo Clinic Laboratories:
- Calmodulin-Binding Transcription Activator 1 (CAMTA1), Immunostain, Technical Component Only (Mayo ID: CAMTA)
- FosB, Immunostain, Technical Component Only (Mayo ID: BFOS)
- Retinoblastoma Protein (Rb) Immunostain, Tech Only (Mayo ID: RB1)
- Trypanosoma cruzi IgG Antibody, Lateral Flow Assay, Serum(Mayo ID: RCHAG)
In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories: